Healthcare >> CEO Interviews >> December 18, 2000

James Cour – Cytomedix Inc (cydx)

JAMES A. COUR has been President and Chief Executive Officer of Cytomedix, Inc. since April 2000. Before joining the company, Mr. Cour served for 19 years with Baxter International Inc. in a variety of management positions, most recently as Vice President of Portfolio Strategy. In this capacity Mr. Cour developed a detailed knowledge of many of the new and cutting-edge medical technologies emerging from the US and international health care markets. He is thus particularly well- suited to formulate and direct the company's emerging business strategy. From 1994 to 1996 Mr. Cour served in Japan as General Manager of Operations for Baxter Limited, Baxter's $725 million Japanese operating subsidiary. There he successfully implemented a complex restructuring of the subsidiary's operations, resulting in significant savings and important improvements in customer service levels. Mr. Cour also served as Director of Business Development for Baxter's Global Business Group where he gained in-depth knowledge of the international health care market. He has a Master of Business Administration Degree, with a specialization in Finance, from the University of Chicago Graduate School of Business and a Bachelor of Business Administration Degree, with honors in Accountancy, from the University of Notre Dame. He passed the Uniform Certified Public Accounting Examination and has been admitted to practice as a CPA in the State of Illinois. Profile
TWST: Could we start out with a history and a brief overview of


Mr. Cour: Cytomedix is a biotechnology company, focusing on development

of cellular therapies for the treatment of